Discontinued — last reported Q2 '22
Archer Daniels Midland Short-Term Borrowings increased by 115.4% to $1.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.8%, from $2.77B to $1.72B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows a downward trend with a -17.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.29B | $314.00M | $958.00M | $3.78B | $2.35B | $181.00M | $503.00M | $1.81B | $125.00M | $116.00M | $105.00M | $1.73B | $2.31B | $1.73B | $1.90B | $2.77B | $856.00M | $246.00M | $798.00M | $1.72B |
| QoQ Change | — | -75.6% | +205.1% | +294.3% | -37.7% | -92.3% | +177.9% | +259.6% | -93.1% | -7.2% | -9.5% | >999% | +33.3% | -25.0% | +9.8% | +45.3% | -69.0% | -71.3% | +224.4% | +115.4% |
| YoY Change | — | — | — | — | +82.5% | -42.4% | -47.5% | -52.1% | -94.7% | -35.9% | -79.1% | -4.1% | >999% | >999% | >999% | +59.5% | -63.0% | -85.8% | -58.1% | -37.8% |